Soleno Therapeutics Inc [SLNO] stock prices are up 1.82% to $50.45 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLNO shares have gain 12.24% over the last week, with a monthly amount drifted -27.88%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Soleno Therapeutics Inc [NASDAQ: SLNO] stock has seen the most recent analyst activity on November 18, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $75. Previously, Goldman started tracking the stock with Buy rating on October 07, 2025, and set its price target to $125. On August 20, 2025, Wells Fargo initiated with an Overweight rating and assigned a price target of $123 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $110 on June 23, 2025. Stifel reiterated a Buy rating for this stock on December 02, 2024, but kept the price target unchanged to $74. In a note dated December 02, 2024, Robert W. Baird reiterated an Outperform rating on this stock but restated the target price of $72.
The stock price of Soleno Therapeutics Inc [SLNO] has been fluctuating between $41.50 and $90.32 over the past year. Currently, Wall Street analysts expect the stock to reach $117.33 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $50.45 at the most recent close of the market. An investor can expect a potential return of 132.57% based on the average SLNO price forecast.
Analyzing the SLNO fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -0.9%, Pretax Profit Margin comes in at -0.8%, and Net Profit Margin reading is -0.8%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.26 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.68 points at the first support level, and at 48.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 51.16, and for the 2nd resistance point, it is at 51.88.
Ratios To Look Out For
It’s worth pointing out that Soleno Therapeutics Inc [NASDAQ:SLNO]’s Current Ratio is 16.08. In addition, the Quick Ratio stands at 15.88 and the Cash Ratio stands at 7.42. Considering the valuation of this stock, the price to sales ratio is 27.46, the price to book ratio is 5.48.
Transactions by insiders
Recent insider trading involved Abingworth Bioventures VII LP, Shareholder, that happened on Aug 11 ’25 when 1.35 million shares were purchased. Hirano Patricia C completed a deal on Jul 01 ’25 to sell 3830.0 shares. Meanwhile, Officer PATRICIA HIRANO bought 3830.0 shares on Jul 01 ’25.
